InvenireX
ID: 17664559InvenireX is an advanced PCR laboratory testing developer founded in 2021 by Dan Todd.
2
Funding Rounds
$3.2m
Money raised
Recent Funding Rounds
Overview
InvenireX is an advanced PCR laboratory testing developer founded in 2021 by Dan Todd.
- Website:
- Headquarters: Newcastle upon Tyne
- Social accounts: linkedin
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
Funding
Funding series
Funding Series Analysis
The company InvenireX has raised a total of $3.24m in funding over 2 rounds.
Key Insights:
- InvenireX Seed Round, November 2025: $2.6m
- InvenireX March 2024 Seed Funding Round: $640k